BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Prognosis
245 results:

  • 1. Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study.
    Matsui R; Ida S; Ri M; Makuuchi R; Hayami M; Kumagai K; Ohashi M; Sano T; Nunobe S
    Gastric Cancer; 2024 May; 27(3):611-621. PubMed ID: 38402291
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathologic features and prognosis of 71 patients with gastric cancer and disseminated intravascular coagulation.
    Chen L; Lin J; Chen Y; Yu J; Wang X
    PeerJ; 2023; 11():e16527. PubMed ID: 38034872
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
    Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
    BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The value of lymph nodes ratios in the prognosis of resectable remnant gastric cancer through the retrospective propensity score matching analysis.
    Yang B; Liu T; Cui H; Lu Z; Fang G; Xue X; Luo T
    World J Surg Oncol; 2023 Aug; 21(1):245. PubMed ID: 37563693
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study.
    Rabbani S; Mattsson F; Lagergren J; Xie S
    Acta Oncol; 2023 May; 62(5):438-443. PubMed ID: 37216488
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy.
    Gervaso L; Bottiglieri L; Meneses-Medina MI; Pellicori S; Biffi R; Fumagalli Romario U; De Pascale S; Sala I; Bagnardi V; Barberis M; Cella CA; Fazio N
    Clin Transl Oncol; 2023 Nov; 25(11):3287-3295. PubMed ID: 37084152
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of an RNA modification-related gene predictive model associated with prognosis and immunity in gastric cancer.
    Tuhongjiang A; Wang F; Zhang C; Pang S; Qu Y; Feng B; Amuti G
    BMC Bioinformatics; 2023 Apr; 24(1):147. PubMed ID: 37061682
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Conditional relative survival in nonmetastatic esophagogastric cancer between 2006 and 2020: A population-based study.
    Pape M; Kuijper SC; Vissers PAJ; Ruurda JP; Neelis KJ; van Laarhoven HWM; Verhoeven RHA
    Int J Cancer; 2023 Jun; 152(12):2503-2511. PubMed ID: 36840612
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Association of Thymidine Phosphorylase with gastric cancer prognosis.
    Adachi S; Ohashi H; Mukai H; Kawai M; Hirao T; Shibata K
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1446-1448. PubMed ID: 36733097
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Beyond Median Overall Survival: Estimating Trends for Multiple Survival Scenarios in Patients With Metastatic Esophagogastric cancer.
    Pape M; Kuijper SC; Vissers PAJ; Beerepoot LV; Creemers GJ; van Laarhoven HWM; Verhoeven RHA
    J Natl Compr Canc Netw; 2022 Dec; 20(12):1321-1329.e4. PubMed ID: 36509070
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Clinicopathologic Characteristics and Outcomes of Gastroentero-pancreatic Neuroendocrine Tumors - Experience from A Tertiary cancer Center.
    Ali J; Rahat A; Shah MH; Sajjad M; Malik I; Ikram SI; Ul Qamar MF
    Gulf J Oncolog; 2022 Sep; 1(40):7-14. PubMed ID: 36448065
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The prognostic marker elastin correlates with epithelial-mesenchymal transition and vimentin-positive fibroblasts in gastric cancer.
    Fang T; Zhang L; Yin X; Wang Y; Zhang X; Bian X; Jiang X; Yang S; Xue Y
    J Pathol Clin Res; 2023 Jan; 9(1):56-72. PubMed ID: 36226731
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Scoring system for predicting the prognosis of elderly gastric cancer patients after endoscopic submucosal dissection.
    Ito N; Funasaka K; Fujiyoshi T; Nishida K; Furukawa K; Kakushima N; Furune S; Ohno E; Nakamura M; Horiguchi N; Shibata T; Miyahara R; Haruta JI; Hirooka Y; Fujishiro M; Kawashima H
    Dig Endosc; 2023 Jan; 35(1):67-76. PubMed ID: 36052429
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts.
    Quaas A; Biesma HD; Wagner AD; Verheij M; van Berge Henegouwen MI; Schoemig-Markiefka B; Pamuk A; Zander T; Siemanowski J; Sikorska K; Egthuijsen JMP; Meershoek-Klein Kranenbarg EM; van de Velde CJH; Buettner R; Alakus H; Cats A; Ylstra B; van Laarhoven HWM; van Grieken NCT
    Eur J Cancer; 2022 Sep; 173():95-104. PubMed ID: 35863110
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
    Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
    World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma.
    Wang X; Espin-Garcia O; Jiang DM; Allen MJ; Ma LX; Bach Y; Chen EX; Darling G; Yeung JC; Wong RKS; Veit-Haibach P; Kalimuthu S; Jang RW; Elimova E
    Oncology; 2022; 100(8):439-448. PubMed ID: 35764050
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. No detrimental effect of perioperative blood transfusion on recurrence in 2905 stage II/III gastric cancer patients: A propensity-score matching analysis.
    Song JH; Shin HJ; Lee S; Park SH; Cho M; Kim YM; Hyung WJ; Kim HI
    Eur J Surg Oncol; 2022 Oct; 48(10):2132-2140. PubMed ID: 35672232
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic value of tumor-infiltrating CD163
    Kinoshita J; Fushida S; Yamaguchi T; Moriyama H; Saito H; Shimada M; Terai S; Okamoto K; Nakamura K; Ninomiya I; Yagi S; Inaki N
    BMC Cancer; 2022 Jun; 22(1):608. PubMed ID: 35658848
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced gastric cancer After Neoadjuvant Chemotherapy.
    Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM
    JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.